GLICLAZIDA 60 MG COM LIB PROL CT BL AL AL X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1235202690051
  • GGREM 529920080067607
  • Código de barras 7897076922403

O que a fonte publica

Detentor do registro
RANBAXY FARMACÊUTICA LTDA
Princípios ativos
GLICLAZIDA
Embalagem
60 MG COM LIB PROL CT BL AL AL X 30
Regime de dispensação
Tarja Vermelha
Tipo de produto
Genérico
Classe terapêutica
A10H - ANTIDIABÉTICOS SULFONILOURÉIAS PUROS
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:529920080067607
{
  "name": "GLICLAZIDA 60 MG COM LIB PROL CT BL AL AL X 30",
  "holder": "RANBAXY FARMACÊUTICA LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7897076922403"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "529920080067607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "73.663.650/0001-90",
  "priceRegime": "Regulado",
  "productName": "GLICLAZIDA",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "60 MG COM LIB PROL CT BL AL AL X 30",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "40.59",
    "icms-12": "46.13",
    "icms-17": "48.90",
    "icms-18": "49.50",
    "icms-19": "50.11",
    "icms-20": "50.74",
    "icms-21": "51.38",
    "icms-22": "52.04",
    "icms-23": "52.71",
    "icms-17.5": "49.20",
    "icms-19.5": "50.42",
    "icms-20.5": "51.06",
    "icms-22.5": "52.37",
    "icms-12-alc": "45.57",
    "icms-17-alc": "48.32",
    "icms-18-alc": "48.91",
    "icms-19-alc": "49.51",
    "icms-20-alc": "50.13",
    "icms-21-alc": "50.76",
    "icms-22-alc": "51.41",
    "icms-23-alc": "52.08",
    "withoutTaxes": "40.10",
    "icms-17.5-alc": "48.61",
    "icms-19.5-alc": "49.82",
    "icms-20.5-alc": "50.44",
    "icms-22.5-alc": "51.75"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "GLICLAZIDA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "55.95",
    "icms-12": "63.59",
    "icms-17": "67.40",
    "icms-18": "68.23",
    "icms-19": "69.07",
    "icms-20": "69.94",
    "icms-21": "70.82",
    "icms-22": "71.73",
    "icms-23": "72.66",
    "icms-17.5": "67.82",
    "icms-19.5": "69.50",
    "icms-20.5": "70.38",
    "icms-22.5": "72.19",
    "icms-12-alc": "63.00",
    "icms-17-alc": "66.80",
    "icms-18-alc": "67.62",
    "icms-19-alc": "68.44",
    "icms-20-alc": "69.30",
    "icms-21-alc": "70.17",
    "icms-22-alc": "71.07",
    "icms-23-alc": "72.00",
    "withoutTaxes": "55.44",
    "icms-17.5-alc": "67.20",
    "icms-19.5-alc": "68.87",
    "icms-20.5-alc": "69.73",
    "icms-22.5-alc": "71.54"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "GLICLAZIDA"
  ],
  "therapeuticClass": "A10H - ANTIDIABÉTICOS SULFONILOURÉIAS PUROS",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1235202690051",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "A10H",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:529920080067607"